EcoR1 Capital, LLC — SEC insider filings

SEC reporting owner CIK 1587114. 59 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers the 50 most recent of 59 filings on record, filed 2021-03-25 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PROTHENA CORP PUBLIC LTD CO (PRTA)10% owner53 legs · 2,237,736 sh · $60,247,1494 legs · 7,342,420 sh · $81,680,4062
Zymeworks Inc. (ZYME)Director, 10% owner2245 legs · 10,315,335 sh · $107,392,396—5
ANAPTYSBIO, INC (ANAB)Director, 10% owner614 legs · 1,770,687 sh · $51,405,8561 leg · 668,237 sh · $14,453,966—
First Tracks Biotherapeutics, Inc. (TRAX)10% owner1—1 leg · 4,705,575 sh · $64,999,990—
Aktis Oncology, Inc. (AKTS)Director12 legs · 2,222,222 sh · $39,999,996—10
iTeos Therapeutics, Inc. (ITOS)10% owner12 legs · 4,958,978 sh · $38,685,562——
Corvus Pharmaceuticals, Inc. (CRVS)10% owner1—2 legs · 5,000,000 sh · $25,059,900—
Nuvation Bio Inc. (NUVB)Director416 legs · 11,483,868 sh · $21,473,8572 legs · 208,142 sh · $2,072,642—
Odonate Therapeutics, Inc. (ODT)10% owner11 leg · 185,941 sh · $308,6624 legs · 5,887,610 sh · $9,741,063—
Voyager Therapeutics, Inc. (VYGR)10% owner22 legs · 477,400 sh · $2,662,0473 legs · 902,400 sh · $7,142,343—

+5 more issuers among the filings shown — every filing appears in the table below.

Insider filings — EcoR1 Capital, LLC

FiledFormIssuerReported transactionsSource
2026-11-184ANAPTYSBIO, INC (ANAB)
jointly with NODELMAN OLEG
Purchase (P): 84,120 @ $45.66 · Purchase (P): 152,367 @ $45.66 · Purchase (P): 138,093 @ $46.54EDGAR
2026-05-114Atara Biotherapeutics, Inc. (ATRA)Purchase (P): 507,407 @ $9.35EDGAR
2026-04-224First Tracks Biotherapeutics, Inc. (TRAX)Sale (S): 4,705,575 @ $13.81EDGAR
2026-01-124Aktis Oncology, Inc. (AKTS)
jointly with NODELMAN OLEG
Conversion (C): 2,270,879 · Conversion (C): 202,862 · Conversion (C): 128,506 · Purchase (P): 2,077,779 @ $18 · Purchase (P): 144,443 @ $18 · Conversion (C): 9,913,810 (derivative) · +6 moreEDGAR
2025-07-304Adaptimmune Therapeutics PLC (ADAP)Sale (S): 33,931,740 @ $0.11 · Sale (S): 2,687,460 @ $0.10 · Sale (S): 27,433,338 @ $0.10EDGAR
2025-06-274Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Option exercise/expiry (X): 5,086,480 @ $0.00 · Tax withholding (F): 41 @ $12.71 · Option exercise/expiry (X): 5,086,521 (derivative) @ $0EDGAR
2025-05-194Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 49,502 @ $11.43 · Purchase (P): 5,919 @ $11.78EDGAR
2025-05-164iTeos Therapeutics, Inc. (ITOS)Purchase (P): 1,658,978 @ $7.41 · Purchase (P): 3,300,000 @ $8EDGAR
2025-05-064PROTHENA CORP PUBLIC LTD CO (PRTA)Sale (S): 3,317,938 @ $8.36 · Sale (S): 977,693 @ $8.11 · Sale (S): 1,984,053 @ $7.64EDGAR
2025-04-184Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 73,953 @ $11.16 · Purchase (P): 54,760 @ $11.52EDGAR
2025-04-074Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 120,770 @ $11.84 · Purchase (P): 196,438 @ $11.17EDGAR
2025-04-024Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 4,397 @ $11.75 · Purchase (P): 48,658 @ $11.60 · Purchase (P): 74,360 @ $11.85EDGAR
2025-03-274Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 53,501 @ $12.91 · Purchase (P): 43,848 @ $12.24EDGAR
2025-03-244Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 73,476 @ $12.93 · Purchase (P): 31,033 @ $12.78 · Purchase (P): 22,689 @ $13.08EDGAR
2025-03-194Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 56,277 @ $12.23 · Purchase (P): 113,880 @ $12.65 · Purchase (P): 58,306 @ $12.64EDGAR
2025-03-134Zymeworks Inc. (ZYME)
jointly with NODELMAN OLEG
Purchase (P): 320,690 @ $11.49 · Purchase (P): 292,934 @ $12.25 · Purchase (P): 468,356 @ $12.48EDGAR
2025-01-214Zymeworks Inc. (ZYME)Purchase (P): 121,681 @ $13.88 · Purchase (P): 19,748 @ $13.87EDGAR
2025-01-154Zymeworks Inc. (ZYME)Purchase (P): 74,125 @ $13.39 · Purchase (P): 54,500 @ $13.56 · Purchase (P): 39,029 @ $14.01EDGAR
2025-01-104Zymeworks Inc. (ZYME)Purchase (P): 21,021 @ $14.07 · Purchase (P): 204,098 @ $13.13EDGAR
2025-01-024ANAPTYSBIO, INC (ANAB)
jointly with NODELMAN OLEG
Purchase (P): 65,184 @ $12.92 · Purchase (P): 13,268 @ $12.93 · Purchase (P): 6,646 @ $12.95EDGAR
2025-01-024Zymeworks Inc. (ZYME)Purchase (P): 58,988 @ $14.47 · Purchase (P): 146,501 @ $14.57 · Purchase (P): 157,880 @ $14.78EDGAR
2024-12-274Zymeworks Inc. (ZYME)Purchase (P): 11,958 @ $14.12 · Purchase (P): 16,692 @ $14.38 · Purchase (P): 101,659 @ $14.49EDGAR
2024-12-264/AZymeworks Inc. (ZYME)Purchase (P): 298,818 @ $13.53 · Purchase (P): 704,488 @ $14.08 · Purchase (P): 251,502 @ $14.25EDGAR
2024-12-234Mersana Therapeutics, Inc. (MRSN)Other (J): 8,036,688 · Other (J): 8,036,688 (derivative)EDGAR
2024-12-234Zymeworks Inc. (ZYME)Purchase (P): 5,086,521 (derivative) @ $9.83EDGAR
2024-11-084Tango Therapeutics, Inc. (TNGX)Sale (S): 1,494,558 @ $3.28 · Sale (S): 62,318 @ $3.29 · Sale (S): 1,143,124 @ $2.92EDGAR
2024-08-164ANAPTYSBIO, INC (ANAB)Purchase (P): 273,972 @ $36.50EDGAR
2023-12-284Zymeworks Inc. (ZYME)Purchase (P): 5,086,521 (derivative) @ $9.83EDGAR
2023-09-224/ANuvation Bio Inc. (NUVB)
jointly with NODELMAN OLEG, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 5,143,000 @ $1.26 · Purchase (P): 117,100 @ $1.36 · Purchase (P): 53,000 @ $1.36EDGAR
2023-09-214Nuvation Bio Inc. (NUVB)
jointly with NODELMAN OLEG, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 5,143,000 @ $1.26 · Purchase (P): 117,100 @ $1.36 · Purchase (P): 53,000 @ $1.36EDGAR
2023-06-214Zymeworks Inc. (ZYME)Purchase (P): 3,350,000 @ $8.12EDGAR
2023-05-024Panacea Acquisition Corp. II (PANA)
jointly with EcoR1 Panacea Holdings II, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC, NODELMAN OLEG
Disposition to issuer (D): 545,000EDGAR
2023-03-304Zymeworks Inc. (ZYME)Purchase (P): 200,000 @ $8EDGAR
2023-01-234Zymeworks Inc. (ZYME)Purchase (P): 144,100 @ $9.49 · Purchase (P): 163,400 @ $9.88EDGAR
2023-01-184Zymeworks Inc. (ZYME)Purchase (P): 342,100 @ $9.81 · Purchase (P): 440,000 @ $9.80 · Purchase (P): 203,000 @ $10.00EDGAR
2023-01-124Zymeworks Inc. (ZYME)Purchase (P): 920,000 @ $7.65 · Purchase (P): 106,300 @ $7.87EDGAR
2023-01-114Voyager Therapeutics, Inc. (VYGR)Sale (S): 456,000 @ $7.67 · Sale (S): 336,400 @ $8.05 · Sale (S): 110,000 @ $8.50EDGAR
2022-06-234Voyager Therapeutics, Inc. (VYGR)Purchase (P): 101,400 @ $5.28 · Purchase (P): 376,000 @ $5.66EDGAR
2022-05-094ANAPTYSBIO, INC (ANAB)
jointly with NODELMAN OLEG
Purchase (P): 668,237 @ $21.63 · Sale (S): 668,237 @ $21.63EDGAR
2022-05-094PROTHENA CORP PUBLIC LTD CO (PRTA)Purchase (P): 1,062,736 @ $29.02 · Sale (S): 1,062,736 @ $29.02EDGAR
2022-01-124PROTHENA CORP PUBLIC LTD CO (PRTA)Purchase (P): 300,000 @ $37.50EDGAR
2021-12-104Odonate Therapeutics, Inc. (ODT)Purchase (P): 185,941 @ $1.66 · Sale (S): 185,941 @ $1.66 · Sale (S): 156,669 @ $1.82 · Sale (S): 5,000,000 @ $1.66 · Sale (S): 545,000 @ $1.55EDGAR
2021-11-304Nuvation Bio Inc. (NUVB)
jointly with NODELMAN OLEG, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 151,544 @ $10.45 · Sale (S): 151,544 @ $10.45 · Purchase (P): 56,598 @ $8.64 · Sale (S): 56,598 @ $8.64 · Purchase (P): 163,268 @ $7.69 · Purchase (P): 21,758 @ $7.69EDGAR
2021-10-014Corvus Pharmaceuticals, Inc. (CRVS)Sale (S): 3,000,000 @ $5.04 · Sale (S): 2,000,000 @ $4.96EDGAR
2021-06-224PROTHENA CORP PUBLIC LTD CO (PRTA)Option exercise/expiry (X): 250,000 @ $30 · Option exercise/expiry (X): 2,500 (derivative) @ $0EDGAR
2021-05-044ANAPTYSBIO, INC (ANAB)
jointly with NODELMAN OLEG
Purchase (P): 35,700 @ $23.16 · Purchase (P): 20,800 @ $23.31 · Purchase (P): 165,000 @ $23.25EDGAR
2021-04-274ANAPTYSBIO, INC (ANAB)
jointly with NODELMAN OLEG
Purchase (P): 99,600 @ $23.54 · Purchase (P): 13,900 @ $23.80 · Purchase (P): 33,800 @ $23.82EDGAR
2021-04-134Panacea Acquisition Corp. II (PANA)
jointly with EcoR1 Panacea Holdings II, LLC, NODELMAN OLEG, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 545,000 @ $10EDGAR
2021-04-134Nuvation Bio Inc. (NUVB)
jointly with NODELMAN OLEG, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, EcoR1 Panacea Holdings, LLC, Biotech Opportunity GP, LLC
Purchase (P): 262,230 @ $10.03 · Purchase (P): 37,770 @ $10.03 · Purchase (P): 116,255 @ $9.49 · Purchase (P): 16,745 @ $9.49 · Purchase (P): 27,534 @ $10.27 · Purchase (P): 3,966 @ $10.27EDGAR
2021-03-254PROTHENA CORP PUBLIC LTD CO (PRTA)Purchase (P): 875,000 @ $20.75EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1587114 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs